ANTI-INFLIXIMAB (IFX) ANTIBODIES - ANVISA Registration 80102512585
Access comprehensive regulatory information for ANTI-INFLIXIMAB (IFX) ANTIBODIES in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102512585 and manufactured by manufacturer not specified. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MรDICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including BODITECH MED INC., PROGENIKA BIOPHARMA S.L., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
ANTICORPOS ANTI-INFLIXIMAB (IFX)
LISA-TRACKER ANTI-INFLIXIMAB
BIOSYNEX SA
10338930315
Jul 22, 2024
ANTICORPOS ANTI-INFLIXIMAB (IFX)
Famรญlia AFIAS Total Anti-Infliximab
BODITECH MED INC.
10350840430
Nov 07, 2022
ANTICORPOS ANTI-INFLIXIMAB (IFX)
Famรญlia AFIAS Free Anti-Infliximab
BODITECH MED INC.
10350840427
Oct 27, 2022
ANTICORPOS ANTI-INFLIXIMAB (IFX)
PROMONITOR ANTI-IFX
PROGENIKA BIOPHARMA S.L.
80134860239
Jul 03, 2017

